Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure

[1]  J. Mordenti,et al.  Effect of dose on pharmacokinetics and serum bactericidal activity of mezlocillin , 1987, Antimicrobial Agents and Chemotherapy.

[2]  S. Schimpff.  Empiric antibiotic therapy for granulocytopenic cancer patients. , 1986, The American journal of medicine.

[3]  L. Young,et al.  Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients. , 1984, The American journal of medicine.

[4]  K. Borner,et al.  Kinetic interactions between azlocillin, cefotaxime, and cefotaxime metabolites in normal and impaired renal function , 1984, Clinical pharmacology and therapeutics.

[5]  U. Gundert-Remy,et al.  Nonlinear mezlocillin kinetics due to dose‐dependent metabolism , 1983, Clinical pharmacology and therapeutics.

[6]  H. Lode,et al.  Serum bactericidal activity and kinetics of azlocillin and moxalactam after single and combined administration. , 1983, The Journal of antimicrobial chemotherapy.

[7]  J. Doluisio.  Clinical pharmacokinetics of cefotaxime in patients with normal and reduced renal function. , 1982, Reviews of infectious diseases.

[8]  R. Jones,et al.  Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity. , 1982, Reviews of infectious diseases.

[9]  R. Ings,et al.  The pharmacokinetics of cefotaxime and its metabolites in subjects with normal and impaired renal function. , 1982, Reviews of infectious diseases.

[10]  J. D. Coombes.  Metabolism of cefotaxime in animals and humans. , 1982, Reviews of infectious diseases.

[11]  K. Desante,et al.  Effect of probenecid on the pharmacokinetics of moxalactam , 1982, Antimicrobial Agents and Chemotherapy.

[12]  H. Neu,et al.  Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam. , 1982, The Journal of antimicrobial chemotherapy.

[13]  J. Houston,et al.  Drug metabolite kinetics. , 1981, Pharmacology & therapeutics.

[14]  F. Luft,et al.  Mezlocillin pharmacokinetics in renal impairment , 1980, Clinical pharmacology and therapeutics.

[15]  J. Arnaud,et al.  Biliary elimination of mezlocillin: an experimental and clinical study , 1980, Antimicrobial Agents and Chemotherapy.

[16]  E. Mellits,et al.  Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. , 1980, The New England journal of medicine.

[17]  J. Mcewen,et al.  Metabolism of cefotaxime in animals and man. , 1980, The Journal of antimicrobial chemotherapy.

[18]  F. Esmieu,et al.  Pharmacokinetics of cefotaxime in normal human volunteers. , 1980, The Journal of antimicrobial chemotherapy.

[19]  L. Benet,et al.  Noncompartmental determination of the steady-state volume of distribution. , 1979, Journal of pharmaceutical sciences.

[20]  L. Verbist,et al.  Mezlocillin pharmacokinetics. Comparison with ampicillin and influence of probenecid. , 1979, Arzneimittel-Forschung.

[21]  T. Bergan.  Pharmacokinetics of Mezlocillin in Healthy Volunteers , 1978, Antimicrobial Agents and Chemotherapy.

[22]  H. Neu,et al.  Synergy of Azlocillin and Mezlocillin Combined With Aminoglycoside Antibiotics and Cephalosporins , 1978, Antimicrobial Agents and Chemotherapy.

[23]  M. Reidenberg.  The biotransformation of drugs in renal failure. , 1977, The American journal of medicine.

[24]  G. Bodey,et al.  Mezlocillin: In Vitro Studies of a New Broad-Spectrum Penicillin , 1977, Antimicrobial Agents and Chemotherapy.

[25]  M. Reidenberg,et al.  The rate of procaine hydrolysis in serum of normal subjects and diseased patients , 1972, Clinical pharmacology and therapeutics.

[26]  Kirby Wm,et al.  Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients. , 1971 .

[27]  W. M. Kirby,et al.  Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients. , 1971, Postgraduate medical journal.

[28]  M. Schwartz,et al.  Apparent effect of probenecid on the distribution of penicillins in man , 1968, Clinical pharmacology and therapeutics.